interaction records 54 assistance programs 55 0 personal data stored
OmniRx › Tools › Generic competition check › Lenacapavir Sodium

Generic competition · all medicines · read 12 November 2026

Is there a generic of Lenacapavir Sodium, and who makes it?

Lenacapavir Sodium appears in 2 dosage-form groups in the FDA Orange Book as of 12 November 2026, with no generic maker listed as marketed. 2 groups have a brand listed as marketed and no generic listed as marketed. The data does not state why, and it does not state that one is coming. This is the Orange Book's listing, not a forecast.

Compiled and checked by Vincent Wesley Couey (ORCID 0009-0005-6869-308X) from the Orange Book data files, downloaded 12 November 2026.

Not medical advice. This page reports what the FDA's Orange Book lists, not what a pharmacy has in stock, what anything costs, or whether a generic is right for you. Ask your pharmacist or prescriber about your own medicine.
Lenacapavir Sodium2 dosage-form groups in the Orange Book
0generic makers listed
  1. Lenacapavir Sodium appears in 2 dosage-form groups in the FDA Orange Book as of 12 November 2026, with no generic maker listed as marketed.
  2. 2 groups have a brand listed as marketed and no generic listed as marketed. The data does not state why, and it does not state that one is coming.
  3. Patents and exclusivities are shown as listed by the application holder; the Orange Book does not rule on them, and a listed patent is not a statement that a generic is blocked. This says nothing about price, supply or quality.

Solution, Subcutaneous

Brand listed, no generic listed as marketed

Brand listed as marketed: Sunlenca and Yeztugo. No generic is listed as marketed.

20202025203020352040204501brand 2022data datePatent 9951043 listed to expire 28 February 2034Patent 10654827 listed to expire 17 August 2037Patent 10071985 listed to expire 17 August 2037Patent 11267799 listed to expire 16 August 2038Patent 12594267 listed to expire 15 July 2039Patent 11807625 listed to expire 25 November 2040Patent 11944611 listed to expire 28 August 2041Exclusivity NCE to 22 December 2027Exclusivity NP to 18 June 2028
generic makers listed as marketed, by first approvallisted patent expiryexclusivity end

Patents and exclusivities still listed

  • 22 December 2027Exclusivity NCE Sunlenca
  • 18 June 2028Exclusivity NP Yeztugo
  • 28 February 2034Patent 9951043 drug substance
  • 17 August 2037Patent 10654827
  • 17 August 2037Patent 10071985 drug substance
  • 16 August 2038Patent 11267799 drug substance
  • 15 July 2039Patent 12594267 drug product
  • 25 November 2040Patent 11807625
  • 28 August 2041Patent 11944611

Tablet, Oral

Brand listed, no generic listed as marketed

Brand listed as marketed: Sunlenca and Yeztugo. No generic is listed as marketed.

20202025203020352040204501brand 2022data datePatent 9951043 listed to expire 28 February 2034Patent 10654827 listed to expire 17 August 2037Patent 10071985 listed to expire 17 August 2037Patent 11267799 listed to expire 16 August 2038Patent 11944611 listed to expire 28 August 2041Exclusivity NCE to 22 December 2027Exclusivity NP to 18 June 2028Exclusivity I-999 to 27 August 2029
generic makers listed as marketed, by first approvallisted patent expiryexclusivity end

Patents and exclusivities still listed

  • 22 December 2027Exclusivity NCE Sunlenca
  • 18 June 2028Exclusivity NP Yeztugo
  • 27 August 2029Exclusivity I-999 Sunlenca
  • 28 February 2034Patent 9951043 drug substance
  • 17 August 2037Patent 10654827
  • 17 August 2037Patent 10071985 drug substance
  • 16 August 2038Patent 11267799 drug substance
  • 28 August 2041Patent 11944611

US Food and Drug Administration, Orange Book data files, downloaded 12 November 2026. A listed patent is not a ruling that a generic is blocked, and no figure here says anything about price, supply or quality. Check the Orange Book.

Where can you go from this result?

Open it in the check to search another medicine, or see every brand with no generic listed. The FDA explains generic approval in how generic drugs are approved and the FDA generic drug facts, and the Orange Book itself is the FDA Orange Book. To check what is available now, ask your pharmacist, and see the FDA drug shortages page.